GlaxoSmithKline Capital PLC EMTN Prospectus Supplement Update (1766G)
14 March 2020 - 4:32AM
UK Regulatory
TIDMAG99
RNS Number : 1766G
GlaxoSmithKline Capital PLC
13 March 2020
Issued: 13 March 2020, London UK - LSE Announcement
Publication of Supplementary Prospectus
The following supplementary prospectus dated 13 March 2020 has
been approved by the UK Listing Authority and is available for
viewing:
GlaxoSmithKline plc, GlaxoSmithKline Capital plc and GSK Capital
K.K. GBP20,000,000,000 Euro Medium Term Note Programme
Copies of the supplementary prospectus and the documents
incorporated by reference within it have been submitted to the
National Storage Mechanism and will shortly be available for
inspection at and can be downloaded from:
www.morningstar.co.uk/uk/NSM
For further information, please contact:
GlaxoSmithKline plc
980 Great West Road
Brentford
Middlesex
TW8 9GS
United Kingdom
Enquiries:
UK Media enquiries: David Mawdsley (020) 8047 5564
Simon Steel (020) 8047 3763
European Analyst/Investor
enquiries: James Dodwell (020) 8047 2406
Danielle Smith (020) 8047 0932
BASIS ON WHICH YOU MAY ACCESS THE SUPPLEMENTARY PROSPECTUS
Please note that the information contained in the supplementary
prospectus may be addressed to and/or targeted at persons who are
residents of particular countries (specified in the base
prospectus) only and is not intended for use and should not be
relied upon by any person outside these countries and/or to whom
the offer contained in the base prospectus is not addressed. Prior
to relying on the information contained in the supplementary
prospectus you must ascertain from the base p rospectus whether or
not you are part of the intended addressees of the information
contained therein.
Your right to access this service is conditional upon complying
with the above.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
PSPSFAFWDESSEED
(END) Dow Jones Newswires
March 13, 2020 13:32 ET (17:32 GMT)
Glaxosmsc 5.25% (LSE:AG99)
Historical Stock Chart
From Nov 2024 to Dec 2024
Glaxosmsc 5.25% (LSE:AG99)
Historical Stock Chart
From Dec 2023 to Dec 2024